| Financial Year |
March 31 2023 |
| Monetary Funds |
282,245,196.54 |
| Held-for-trading Financial Assets |
950,152,658.76 |
| Notes Receivable |
-- |
| Accounts Receivable |
40,063,184.52 |
| Advances to Suppliers |
5,261,503.97 |
| Other Receivables |
2,459,078.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,606,140.85 |
| Dividend Receivable |
-- |
| Inventories |
76,497,420.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,498,324.46 |
| Total Current Assets |
1,365,177,367.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
223,702,171.52 |
| Under-construction Projects |
190,967,283.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,224,532.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,088,993.07 |
| Deferred Income Tax Assets |
1,713,316.12 |
| Other Non-Current Assets |
21,945,599.16 |
| Sub-Total of Non-Current Assets |
481,970,527.96 |
| Total Assets |
1,847,147,895.30 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,398,080.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,180,546.21 |
| Taxes Payable |
4,079,390.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
137,694.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
243,428.49 |
| Other Current Liabilities |
149,838.98 |
| Sub-Total of Current Liabilities |
86,844,138.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,032,584.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,082,110.07 |
| Total Liabilities |
94,926,248.64 |
| Paid-In Capital(Or Share Stock) |
94,035,122.00 |
| Capital Surplus |
1,205,665,164.81 |
| Surplus Reserve |
25,643,159.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
426,878,200.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,752,221,646.66 |
| Owner's Equity（Stockholder's Equity） |
1,752,221,646.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,847,147,895.30 |
